Vermillion

VRML NASDAQ
0.8177
-0.0213
-2.54%
已收盘, 16:00 07/18 EDT
开盘
0.8400
昨收
0.8390
最高
0.8400
最低
0.7726
成交量
40.03万
成交均量(3M)
16.12万
52周最高
1.570
52周最低
0.2701
换手率
0.41%
市值
7,911.32万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Vermillion VRML股票价格,Vermillion股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Vermillion, Inc. is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor prior to planned surgery. It developed OVA1 through pre-clinical studies in collaboration with various academic medical centers encompassing over 2,500 clinical samples. OVA1 is validated in a multi-center clinical trial encompassing approximately 30 sites reflective of the diverse nature of the clinical centers, at which ovarian adnexal masses are evaluated. Its ASPiRA LABS is a laboratory that provides diagnostic services using a biomarker-based diagnostic algorithm to inform clinical decision making and personalized treatment plans.
展开 >

最近浏览

名称
价格
涨跌幅